Publications

5891 Results

Adenoma recurrences after resection of colorectal carcinoma: Results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study

Authors
DZJ Chu;K Chansky;DS Alberts;FL Meyskens;CM Fenoglio-Preiser;SE Rivkin;GM Mills;JK Giguere;GE Goodman;JL Abbruzzese;SM Lippman
Journal / Conference
Annals of Surgical Oncology 10(8):870-875
Year
2003
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9041

High-dose ifosfamide with mesna and granuloctye-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma

Authors
SM Talbot;C Rankin;RN Taub;SP Balcerzak;N Bhoopalam;RA Chapman;LH Baker;EL Middleman;KH Antman
Journal / Conference
Cancer 98(2):331-336
Year
2003
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-9341

Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group study S9504

Authors
DR Gandara;K Chansky;KS Albain;BR Leigh;LE Gaspar;PN Lara;H Burris;P Gumerlock;JP Kuebler;JD Bearden;J Crowley;R Livingston
Journal / Conference
Journal of Clinical Oncology 21(10):2004-2010
Year
2003
Research Committee(s)
Lung
Study Number(s)
SWOG-9504

Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression

Authors
DL Stirewalt;FR Appelbaum;CL Willman;RA Zager;DE Banker
Journal / Conference
Leukemia Research 27:133-145
Year
2003
Research Committee(s)
Leukemia

Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: Results from an Intergroup phase II trial

Authors
ML Rothenberg;PY Liu;PS Braley;SP Wilczynski;EV Hannigan;S Wadler;G Stuart;C Jiang;M Markman;DS Alberts
Journal / Conference
Journal of Clinical Oncology 21(7):1313-1319
Year
2003
Research Committee(s)
Gynecologic
Study Number(s)
S9619

Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin, vincristine, and prednisone may improve survival in intermediate and high grade lymphoma: a phase II study of the Southwest Oncology Group (SWOG 9349)

Authors
DW Blayney;ML LeBlanc;T Grogan;ER Gaynor;RA Chapman;CH Spiridonidis;SA Taylor;SI Bearman;TP Miller;RI Fisher
Journal / Conference
Journal of Clinical Oncology 21(13):2466-2473
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8903, SWOG-9349

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

Authors
HB Grossman;RB Natale;CM Tangen;VO Speights;NJ Vogelzang;DL Trump;RW de Vere White;MF Sarosdy;DP Wood Jr;D Raghavan;ED Crawford
Journal / Conference
New England Journal of Medicine 349(9):859-866
Year
2003
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8710 (INT-0080) (EST-1887) (CALGB-8891)

Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501

Authors
WS Velasquez;D Lew;TM Grogan;CH Spiridonidis;SP Balcerzak;SR Dakhil;TP Miller;K Lanier;RA Chapman;RI Fisher
Journal / Conference
Journal of Clinical Oncology 21(10):1996-2003
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9501

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial

Authors
PJ Stiff;JM Unger;SJ Forman;AR McCall;M LeBlanc;AP Nademanee;BJ Bolwell;RI Fisher
Journal / Conference
Biology of Blood and Marrow Transplantation 9:529-539
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9011

Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV

Authors
S deVos;U Krug;WK Hofmann;GS Pinkus;SH Swerdlow;W Wachsman;TM Grogan;JW Said;HP Koeffler
Journal / Conference
Diagnostic Molecular Pathology 12(1):35-43
Year
2003
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819